S1300: Pemetrexed Disodium With or Without Crizotinib in Treating Patients With Stage IV Non-Small Cell Lung Cancer That Has Progressed After Crizotinib
Stopped science has moved forward and there is no intent to complete the study
Conditions
- Adenocarcinoma of the Lung
- Large Cell Lung Cancer
- Recurrent Non-small Cell Lung Cancer
- Stage IV Non-small Cell Lung Cancer
Interventions
- DRUG: crizotinib
- DRUG: pemetrexed disodium
- OTHER: laboratory biomarker analysis
- OTHER: pharmacological study
Sponsor
SWOG Cancer Research Network
Collaborators